Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - CASH & EQUIVALENTS
Cash & Equivalents LTRN - Lantern Pharma Inc.
21.9 M
LAST VALUE
-34.75%
2 YEAR CAGR
118.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR